Skip to main content
. 2018 Feb 1;34(2):171–177. doi: 10.1089/aid.2017.0093

Table 1.

Background of Scholars in the Mentored HIV Prevention Trials Network Scholars Program at Time of Application (2010–2015), Cohorts 1–6 (N = 26)

  n (%)
Self-identified sex
 Men 6 (23)
 Women 20 (77)
Age in years
 24–29 1 (4)
 30–34 17 (65)
 35–39 4 (15)
 40–44 3 (12)
 45–49 1 (4)
Self-identified race/ethnicity
 Black/African American 22 (85)
 Hispanic/Latino/Latina 4 (15)
State/Venue of residence
 U.S. northeast (Maryland; Washington, DC; Massachusetts; New York; Pennsylvania) 11 (42)
 U.S. south (Arkansas; Georgia; Mississippi; North Carolina; Texas; Virginia) 9 (35)
 U.S. west (California) 3 (12)
 U.S. midwest (Illinois) 2 (8)
 Canada (U.S. citizen) 1 (4)
Scholar project emphasis by study
 Persons who inject drugs (HPTN 037) 4 (15)
 Voluntary testing and counseling (HPTN 043) 2 (8)
 Prevention with positives (HPTN 063) 3 (12)
 Men who have sex with men (HPTN 061) 8 (31)
 Women at risk (HPTN 064) 8 (31)
 Adolescents/youth (HPTN 068) 1 (4)

All HPTN protocols are available at: www.hptn.org/research/studies, accessed December 9, 2017. We did not collect data on the sexual preferences of HPTN scholars and hence we do not know the number who were sexual minorities, for example, same sex preference or transgender.

HPTN, HIV Prevention Trials Network.